CHAPEL HILL, N.C., Apr 2, 2003 (BUSINESS WIRE) -- POZEN Inc.
(Nasdaq: POZN) announced today that John R. Plachetka, Pharm.D., the
company's chairman, president and chief executive officer, will be
speaking to investors at the SunTrust Robinson Humphrey 32nd Annual
Institutional Investor Conference on Wednesday, April 9, at 7:45 a.m.
Eastern Time. Dr. Plachetka will provide an overview of POZEN's
The presentation will be webcast live and archived on POZEN's home
page at www.pozen.com.
POZEN is a pharmaceutical development company committed to
building a portfolio of products with significant commercial potential
in select therapeutic areas. POZEN's initial focus is on developing
products for migraine therapy, a global market expected to exceed
$3 billion this year. The company's common stock is traded on The
Nasdaq Stock Market under the symbol "POZN."
Chief Financial Officer
Director, Investor Relations